Nicolaas J. Boon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nicolaas J. Boon has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Adva Kochavi
The Netherlands Cancer Institute 1 Division of Oncogenomics, Oncode Institute Amsterdam, the Netherlands
1 shared publication Hugo J. Snippert
Oncode Institute, Utrecht, Netherlands
1 shared publication- Jeanine M. L. Roodhart
Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
1 shared publication - Jonne M. Draper
Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands
1 shared publication - Lidwien P. Smabers
Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
1 shared publication - Lodewyk F. A. Wessels
The Netherlands Cancer Institute, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Top Cited Papers
- 17 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6697) , 785-792
DNA damage induces p53-independent apoptosis through ribosome stalling
In response to excessive DNA damage, human cells can activate p53 to induce apoptosis. Cells lacking p53 can still undergo apoptosis upon DNA damage, yet the responsible pathways are unknown. We observed that p53-independent apoptosis in response to DNA damage coincided with translation inhibition, which was characterized by ribosome stalling on rare leucine-encoding UUA codons and globally curtailed translation initiation. A genetic screen identified the transfer RNAse SLFN11 and the kinase GCN2 as factors required for UUA stalling and global translation inhibition, respectively. Stalled ribosomes activated a ribotoxic stress signal conveyed by the ribosome sensor ZAKα to the apoptosis machinery. These results provide an explanation for the frequent inactivation of SLFN11 in chemotherapy-unresponsive tumors and highlight ribosome stalling as a signaling event affecting cell fate in response to DNA damage.
- 17 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6697) , 785-792
Top Cited PapersDNA damage induces p53-independent apoptosis through ribosome stalling
In response to excessive DNA damage, human cells can activate p53 to induce apoptosis. Cells lacking p53 can still undergo apoptosis upon DNA damage, yet the responsible pathways are unknown. We observed that p53-independent apoptosis in response to DNA damage coincided with translation inhibition, which was characterized by ribosome stalling on rare leucine-encoding UUA codons and globally curtailed translation initiation. A genetic screen identified the transfer RNAse SLFN11 and the kinase GCN2 as factors required for UUA stalling and global translation inhibition, respectively. Stalled ribosomes activated a ribotoxic stress signal conveyed by the ribosome sensor ZAKα to the apoptosis machinery. These results provide an explanation for the frequent inactivation of SLFN11 in chemotherapy-unresponsive tumors and highlight ribosome stalling as a signaling event affecting cell fate in response to DNA damage.